{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:22:20Z","timestamp":1779927740510,"version":"3.53.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T00:00:00Z","timestamp":1645488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EMR\/2016\/007246"],"award-info":[{"award-number":["EMR\/2016\/007246"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jbc.2022.101772","type":"journal-article","created":{"date-parts":[[2022,2,24]],"date-time":"2022-02-24T02:01:34Z","timestamp":1645668094000},"page":"101772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Structure-guided affinity maturation of a single-chain variable fragment antibody against the Fu-bc epitope of the dengue virus envelope protein"],"prefix":"10.1016","volume":"298","author":[{"given":"Animesh","family":"Sarker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek Singh","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Fahim","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1156-9596","authenticated-orcid":false,"given":"Rinkoo Devi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2022.101772_bib1","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.101772_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3527(08)00401-6","article-title":"The history and evolution of human dengue emergence","volume":"72","author":"Vasilakis","year":"2008","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.jbc.2022.101772_bib3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CMR.00035-09","article-title":"Dengue virus pathogenesis: An integrated view","volume":"22","author":"Martina","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jbc.2022.101772_bib4","article-title":"Current status of vaccines against dengue virus","author":"Casta\u00f1o-Osorio","year":"2018","journal-title":"Dengue Fever - a Resilient Threat in the Face of Innovation"},{"key":"10.1016\/j.jbc.2022.101772_bib5","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00705-013-1645-3","article-title":"Secondary infection as a risk factor for dengue hemorrhagic fever\/dengue shock syndrome: An historical perspective and role of antibody-dependent enhancement of infection","volume":"158","author":"Guzman","year":"2013","journal-title":"Arch. Virol."},{"key":"10.1016\/j.jbc.2022.101772_bib6","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(14)61060-6","article-title":"Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in asia: A phase 3, randomised, observer-masked, placebo-controlled trial","volume":"384","author":"Capeding","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jbc.2022.101772_bib7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1411037","article-title":"Efficacy of a tetravalent dengue vaccine in children in Latin America","volume":"372","author":"Villar","year":"2015","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jbc.2022.101772_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nri.2017.148","article-title":"Passive immunotherapy of viral infections: \u201csuper-antibodies\u201d enter the fray","volume":"18","author":"Walker","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2022.101772_bib9","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.jbc.2022.101772_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nature14411","article-title":"Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117","volume":"522","author":"Caskey","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.101772_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MOH.0000000000000191","article-title":"The use of convalescent plasma to treat emerging infectious diseases: Focus on ebola virus disease","volume":"22","author":"Winkler","year":"2015","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.jbc.2022.101772_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.bsheal.2021.02.001","article-title":"An update to monoclonal antibody as therapeutic option against COVID-19","volume":"3","author":"Deb","year":"2021","journal-title":"Biosafety and Health"},{"key":"10.1016\/j.jbc.2022.101772_bib13","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing monoclonal antibodies for treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jbc.2022.101772_bib14","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1128\/iai.36.3.1036-1041.1982","article-title":"Infection enhancement of dengue type 2 virus in the U-937 human monocyte cell line by antibodies to flavivirus cross-reactive determinants","volume":"36","author":"Brandt","year":"1982","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jbc.2022.101772_bib15","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fcimb.2017.00157","article-title":"Anti-idiotypic antibodies specific to prM monoantibody prevent antibody dependent enhancement of dengue virus infection","volume":"7","author":"Wang","year":"2017","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.jbc.2022.101772_bib16","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1080\/19420862.2016.1227901","article-title":"Techno-economic analysis of a transient plant-based platform for monoclonal antibody production","volume":"8","author":"Nandi","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.jbc.2022.101772_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.antiviral.2015.10.012","article-title":"Antibody with an engineered Fc region as a therapeutic agent against dengue virus infection","volume":"124","author":"Ramadhany","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.jbc.2022.101772_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0092-8674(02)00660-8","article-title":"Structure of dengue virus: Implications for flavivirus organization, maturation, and fusion","volume":"108","author":"Kuhn","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.jbc.2022.101772_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nsmb.2463","article-title":"Cryo-EM structure of the mature dengue virus at 3.5-\u00c5 resolution","volume":"20","author":"Zhang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2022.101772_bib20","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1093\/emboj\/cdg270","article-title":"Structures of immature flavivirus particles","volume":"22","author":"Zhang","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2022.101772_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.101772_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.virol.2009.10.027","article-title":"The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion","volume":"396","author":"Huang","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jbc.2022.101772_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004991","article-title":"Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens","volume":"4","author":"Crill","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2022.101772_bib24","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1128\/JVI.00316-08","article-title":"Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II","volume":"82","author":"Lai","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2022.101772_bib25","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2022.101772_bib26","doi-asserted-by":"crossref","first-page":"12149","DOI":"10.1128\/JVI.01732-06","article-title":"Antibody recognition and neutralization determinants on domains I and II of West Nile virus envelope protein","volume":"80","author":"Oliphant","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2022.101772_bib27","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1038\/emboj.2009.245","article-title":"Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody","volume":"28","author":"Cherrier","year":"2009","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2022.101772_bib28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nature03956","article-title":"Structural basis of West Nile virus neutralization by a therapeutic antibody","volume":"437","author":"Nybakken","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2022.101772_bib29","doi-asserted-by":"crossref","first-page":"9422","DOI":"10.1073\/pnas.0703498104","article-title":"Monoclonal antibody-mediated enhancement of dengue virus infection in\u00a0vitro and in\u00a0vivo and strategies for prevention","volume":"104","author":"Goncalvez","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2022.101772_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209576","article-title":"Designing antibody against highly conserved region of dengue envelope protein by in silico screening of scFv mutant library","volume":"14","author":"Rathore","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2022.101772_bib31","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1007\/s00253-020-10541-y","article-title":"Production and immunogenicity of Fubc subunit protein redesigned from DENV envelope protein","volume":"104","author":"Rathore","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.jbc.2022.101772_bib32","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1073\/pnas.1030237100","article-title":"Protein\u2013protein interactions: Structurally conserved residues distinguish between binding sites and exposed protein surfaces","volume":"100","author":"Ma","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.jbc.2022.101772_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12934-019-1053-9","article-title":"Evaluation of scFv protein recovery from E. coli by in\u00a0vitro refolding and mild solubilization process","volume":"18","author":"Sarker","year":"2019","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.jbc.2022.101772_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1126\/science.3140379","article-title":"Single-chain antigen-binding proteins","volume":"241","author":"Bird","year":"1988","journal-title":"Science"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822002125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925822002125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T03:16:21Z","timestamp":1720062981000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925822002125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S0021925822002125"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2022.101772","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided affinity maturation of a single-chain variable fragment antibody against the Fu-bc epitope of the dengue virus envelope protein","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2022.101772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"101772"}}